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Copyright © 2011 JCBN 2011 This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unre- stricted use, distribution, and reproduction in any medium, pro- vided the original work is properly cited. In inflammatory bowel diseases, interleukin 1β production is
accelerated. Butyrate, a short chain fatty acid, plays an important
role in inflammatory bowel diseases. We investigated the effect
of butyrate on interleukin 1β production in macrophage and
elucidated its underlying mechanism. We stimulated THP 1 cells, a
human premonocytic cell line, by lipopolysaccharide alone and by
butyrate with lipopolysaccharide. Butyrate with lipopolysaccharide
increased interleukin 1β production more than lipopolysaccharide
alone. Butyrate with lipopolysaccharide increased caspase 1 activity
more than lipopolysaccharide alone. As for the phosphorylation
pathway, PD98059 (ERK1/2 inhibitor), SB203580 (p38 MAPK
inhibitor), SP600125 (JNK1/2 inhibitor) decreased caspase 1 activity
and interleukin 1β production to approximately 50% of the controls.
Pertussis toxin (G protein coupled signal transduction pathway
inhibitor) also reduced interleukin 1β production to approximately
50%. Butyrate with lipopolysaccharide increased reactive oxygen
species levels more than lipopolysaccharide alone. The addition of
N acetyl L cysteine reduced reactive oxygen species levels to a
level similar to that of lipopolysaccharide alone. Butyrate with
lipopolysaccharide increased nitric oxide production more than
lipopolysaccharide alone, and the addition of N acetyl L cysteine
reduced the elevated amount of nitric oxide. In conclusions,
butyrate enhances interleukin 1β production by activating caspase 
1, via reactive oxygen species, the phosphorylation of MAPK, and
G protein mediated pathways in lipopolysaccharide stimulated
THP 1 cells.
Key Words: butyrate, macrophage, interleukin 1β (IL 1β), 
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Introduction Inflammatory bowel diseases (IBD), such as ulcerative colitis
(UC) and Crohn’s disease, are characterized by the increased
migration of leukocytes into intestinal mucosal lesions, necrosis
of epithelial cells, and large amounts of enteric ulceration.(1) At
the onset or the active phase in IBD, the production of pro-
inflammatory cytokines and chemokines, particularly interleukin
(IL)-1β, has been observed in these lesions, as has the activation
of caspase-1 in macrophages.(1–3)
Ohkusa et al.(4) have successfully induced UC-like intestinal
tracts in mice by administering enemas using conditioned media
from the obligate anaerobe Fusobacterium varium, isolated from
the intestinal mucosa of UC patients. They suggest that short chain
fatty acids (SCFAs) generated by Fusobacterium varium, parti-
cularly butyrate, played important roles in this induction.
Eftimiadi et al.(5) reported that butyrate enhances IL-1β production
from monocytes. These studies suggest that butyrate induced IL-
1β may be closely and critically associated with the pathogenesis
of the disease. Therefore, we hypothesize that butyrate promotes
the inflammation in mucosa by producing IL-1β from activated
macrophages.
Although IL-1β is regulated by p38 mitogen-activated protein
kinase (MAPK) and extracellular signal-regulated kinases (ERKs)
in human smooth muscle cells,(6) the mechanism by which butyrate
induces IL-1β production in monocyte-macrophages is not yet
understood. In the present study, we investigated the effect of
butyrate on the expression of IL-1β and caspase-1 activity in THP-1
cells, a human premonocytic cell line, and characterized the signal
transduction pathways by which butyrate induces IL-1β production.
Materials and Methods
Materials. Lipopolysaccharide (LPS; Salmonella typhosa
0901) was purchased from Difco (Detroit, MI); PD98059,
SB203580, SP600125, and GF109203X from Calbiochem (La
Jolla, CA); Diphenyleneiodonium chloride from Sigma Chem.
(St. Louis, MO); Ac-YVAD-CHO from BIOMOL (Plymouth,
PA); and pertussis toxin (PTX) from Wako Pure Chem. (Osaka,
Japan). Oligonucleotide primers were synthesized and purified
by BEX (Tokyo, Japan). Total cell protein concentrations were
determined using a DC protein assay kit (Bio-Rad Lab., Hercules,
CA) with bovine serum albumin (Bio-Rad) as the standard. All
other chemicals and materials (except those described below)
were obtained from Nacalai Tesque (Kyoto, Japan).
Cells. THP-1 cells (ATCC, Manassas, VA) were cultured in
RPMI 1640 or HAM’s F12 medium (Nissui Pharmaceutical Co.
Ltd., Tokyo, Japan) with 292 μg/ml L-glutamine, 100 units/ml
penicillin, 100 μg/ml streptomycin, and 10% fetal bovine serum
(FBS) at 37°C and under 5% CO2. Differentiation to macrophages
was induced with 100 nmol/l phorbol 12-myristate 13-acetate
(PMA, Sigma) for 48 h.(7) Cell viability was examined using an
MTT cell viability assay kit (R&D Systems, Minneapolis, MN).
The value for cell viability of the positive control cells, which were
treated with 0.1 μg/ml LPS with or without 1 mmol/l butyrate in
0.5% dimethylsulfoxide (DMSO, v/v), were standardized as
100%. Incubation medium with or without substrates in all experi-
ments did not significantly affect cell viability (data not shown).
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Reverse transcription polymerase chain reaction (RT 
PCR). Total RNA was extracted from THP-1 cells (5.0 × 106)
using TRIzol reagent (Invitrogen, Carlsbad, CA). Single-strand
cDNA was synthesized from 1 μg of total RNA using an RT-PCR
reverse transcription kit (Maxim Biotech, San Francisco, CA).
Incubation was carried out at 37°C for 60 min. The temperature of
the reaction was then raised to 94°C for 5 min in order to make the
enzyme inactive and was then reduced to 4°C. PCR amplification
was performed using a Gene Amp PCR System 9700 (Applied
Biosystems, Carlsbad, CA). For semi-quantitative analysis, the
linearity of amplification of IL-1β and GAPDH cDNA, depending
on the PCR cycle number, was established in preliminary experi-
ments. A total of 30 cycles for IL-1β and GAPDH were performed.
Products were analyzed by Kodak 1-D Image Analysis software
(Eastman Kodak Co. Ltd., NY). The GAPDH primers used were
5'-CCACCCATGGCAAATTCCATGGCA-3' and 5'-TCTAGAC-
GGCAGGTCAGGTCCACC-3'. These were designed to yield a
696-bp product. The IL-1β primers used were 5'-AAACAGAT-
GAAGTGCTCCTTCCA-3' and 5'-GAGAACACCACTTGTT-
GCTCCA-3'. These were designed to yield a 389-bp product.
IL 1β protein production. THP-1 cells were seeded onto a
24-well plate at density of 1.0 × 106 cells/well in RPMI 1640
medium with 292 μg/ml L-glutamine, 100 units/ml penicillin,
100 μg/ml streptomycin, and 10% FBS and cultured at 37°C for
48 h under a humidified atmosphere of 5% CO2. After differentia-
tion with 100 nmol/l PMA, cells were washed with PBS and
treated with PBS or 0.1 μg/ml LPS alone, 1 mmol/l butyrate with
0.1 μg/ml LPS for 3, 6, 12, and 24 h.(8) The control cells were
treated only with phosphate buffered saline (PBS), and positive
control cells were treated with LPS alone. IL-1β protein concen-
tration in the medium was examined by IL-1β Human ELISA Kit
(R&D Systems). The optical density for each specimen were
determined at λex 450 nm, λem 550 nm using a Molecular Devices
microplate reader (Wako).
Caspase 1 activity. Caspase-1 activity was determined using
a caspase-1 fluorometric assay kit (R&D Systems). Cells treated
with or with not chemicals for 6 h were washed in cold PBS at 3
times, then re-suspended in 400 μl of cold lysis buffer and
incubated on ice for 10 min. The cell lysates were pelleted,
followed by transfer of the supernatants to microcentrifuge tubes.
50 μl of 2× reaction buffer with 1 M dithiothreitol (DTT) and 5 μl
of Caspase-1 fluorogenic substrate (WEHD-AFC) were added to
each well, followed by 37°C for 2 h incubation. A control reaction
of treated cells without WEHD-AFC was incubated. The fluoro-
metrical density for each specimen were determined at λex 400 nm,
λem 505 nm using a GENios microplate reader (Wako). The results
are expressed as fold increase, with caspase-1 activity seen in 0.5%
DMSO treated cells (the vehicle control) standardized as 1-fold.
Western blotting. For Western blot analysis, 5 × 106 cells
were lysed in M-PER Mammalian Protein Extraction reagent
(Pierce, Rockford, IL). Denature proteins were separated using
SDS-polyacrylamide gel electrophoresis on a 10 or 15% poly-
acrylamide gel and then transferred onto Immobilon-P membranes
(Millipore, Billerica, MA).(9) We used rabbit anti-human phospho-
p38 MAPK, rabbit anti-human p38 MAPK, rabbit anti-human
phospho-extracellular signal-regulated kinase1/2 (ERK1/2), rabbit
anti-human ERK1/2, rabbit anti-human phospho-c-Jun NH2-
terminal kinase1/2 (JNK1/2), rabbit anti-human JNK1/2, rabbit
anti-human phospho-mitogen-activated protein kinase kinase1/2
(MEK1/2), rabbit anti-human MEK1/2 (R&D Systems, Minneapolis,
MN), rabbit anti-human Caspase-1 (BIOMOL International),
rabbit anti-human actin (Santa Cruz Biotechnology, Santa Cruz,
SA), anti-rabbit antibody horseradish peroxidase-linked immuno-
globulin G (IgG) antibodies (GE Healthcare, Bucks, UK), or non-
labeled rabbit IgG antibodies (Wako Pure Chem.). The blots
were developed using an ECL (GE Healthcare) and the images
were then analysed by Kodak 1-D Image Analysis software. The
ratios of protein expression levels of protein were determined by
dividing the band intensity of the product of interest by that of the
corresponding actin band.
Effects of specific inhibitors. Differentiated cells were
treated with 0.5% (v/v) DMSO alone (vehicle), 1 mmol/l butyrate
with 0.1 μg/ml LPS, or 1 mmol/l butyrate with 0.1 μg/ml LPS in
50 mmol/l of PD98059 (PD), 50 mmol/l of SB203580 (SB),
10 mmol/l of SP600125 (SP), 10 mmol/l of GF109203X (GF),
10 mmol/l of diphenyleneiodonium (DPI), 20 mmol/l of N-acetyl
Fig. 1. Effects of butyrate and lipopolysaccharide (LPS) on interleukin 
1β (IL 1β) mRNA expression in THP 1 cells. THP 1cells were incubated
with 1 mmol/l butyrate alone, 0.1 μg/ml LPS alone, or 1 mmol/l butyrate
with 0.1 μg/ml LPS for 3 h. IL 1β mRNA expressions were detected by
reverse transcription polymerase chain reaction (RT PCR) as described in
Materials and Methods. Representative pictures show mRNA expression
of IL 1β (upper panel) and GAPDH (lower panel).
Fig. 2. Effects of butyrate and lipopolysaccharide (LPS) on interleukin 
1β (IL 1β) protein expression in THP 1 cells. THP 1 cells were seeded
onto a 24 well plate at a density of 1.0 × 106 cells/well in RPMI 1640
medium with 100 nmol/l phorbol 12 myristate 13 acetate (PMA) and
then cultured at 37°C for 48 h under a humidified atmosphere of 5%
CO2. After washing, cells were incubated with medium alone (open
circle), 1 mmol/l butyrate alone (closed triangle), 0.1 μg/ml LPS alone
(closed circle), or 1 mmol/l butyrate with 0.1 μg/ml LPS (open triangle)
for 0, 3, 6, 12, and 24 h. IL 1β protein in medium was examined by
ELISA. Data are expressed as the mean ± SD (n = 5). **p<0.01,
***p<0.001 vs the controls, by Kruskall Wallis variance analysis and
Dunnet’s multiple comparison test. J. Clin. Biochem. Nutr. | January 2012 | vol. 50 | no. 1 | 61
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L-cysteine (NAC), or 100 mmol/l of Ac-YVAD-CHO (YVAD),
which were dissolved in DMSO.(8,9) The positive control cells
were treated with 0.1 μg/ml LPS alone for 6 h (caspase-1 assay) or
24 h (IL-1β assay).
Effects of PTX. THP-1 cells were treated with 100 ng/ml
PTX at 37°C for 60 min. They were then treated with 0.1 μg/ml
LPS alone or 1 mmol/l butyrate with LPS in RPMI 1640 medium
for 24 h.
Detection of reactive oxygen species products. The intra-
cellular production of reactive oxygen species (ROS) was assessed
using a 5-(and-6)-carboxy-2',7'-dichlorodihydrofluorescein di-
acetate fluorescein probe (carboxy-H2DCF-DA, Invitrogen,
Carlsbad, CA).(9) THP-1 cells were treated with 0.1 mg/ml LPS
for 60 min with or without 1 mmol/l butyrate, or with or without
20 mmol/l NAC for 60 min. Then, cells were exposed to 10 mmol/l
carboxy-H2DCFDA in 1 ml PBS for 30 min at 37°C. Cells were
washed twice, re-suspended in 1 ml PBS, and analyzed by fluores-
cence on a FACSCanto (Becton Dickson, Mountain View, CA).
The intensity of DCF in the cells was analyzed by WinMDI ver 2.8
software (http://facs.scripps.edu/software.html).
Nitrite/nitrate quantification. THP-1 cells were seeded
onto a 24-well plate at density of 1.0 × 106 cells/well in HAM’s
F12 medium. Differentiation cells were treated with 0.5 μg/ml
LPS alone or 1 mM butyrate with LPS, and vehicle (0.5% DMSO,
v/v) alone, butyrate with LPS and 20 mM NAC, and LPS with
NAC for 6, 12, 24 h in HAM’s F12 medium. Nitric oxide (NO)
production from incubate medium was determined by measuring
the amount of nitrite/nitrate (NO2–/NO3–), a stable oxidation end
product of NO, NO2/NO3 Assay Kit-C2 (DOJINDO Lab.,
Kumamoto, Japan). The optical density for each specimen were
determined at 540 nm using a Molecular Devices microplate
reader (Wako).
Fig. 3. Effects of butyrate and lipopolysaccharide (LPS) on caspase 1 expression in THP 1 cells. After differentiation, cells were incubated with
phosphate buffered saline (PBS); control, 1 mmol/l butyrate alone, 0.1 μg/ml LPS alone, or 1 mmol/l butyrate with 0.1 μg/ml LPS for 0, 3, 6, 12, and
24 h. Expression of caspase 1 protein and actin was determined by Western blotting. Upper panels show the representative pictures of caspase 1
and actin protein expressions. In lower panels, the values in three independent experiments are expressed as fold increase (the mean ± SD) relative
to that of the controls. **p<0.01 vs the controls, by Kruskall Wallis variance analysis and Dunnet’s multiple comparison test.doi: 10.3164/jcbn.11 22
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Protein determination. Total protein concentrations in lysed
THP-1 cells were determined using a DC Protein Assay kit (Bio-
Rad Lab.), according to the protocol of the manufacturer, with
bovine serum albumin (Bio-Rad Lab.) employed as the standard.
Statistical analysis. Data are expressed as the mean ± SD.
Date were assessed by Kruskall-Wallis variance analysis and
Dunnet’s multiple comparison test or the Mann-Whitney U test.
Statistical analysis was performed by GraphPad Prism ver 4.0
(GraphPad Software Inc., San Diego, CA). Two-tailed values of
p<0.05 were considered to indicate statistical significance.
Results
Butyrate with LPS increases expression of IL 1β mRNA
and protein production. Preliminary experiments using >2
mmol/l butyrate induced excessive toxicity and apoptosis after
24 h (data not shown). A 1 mmol/l butyrate concentration was
therefore used in all subsequent experiments. The expression of
IL-1β m-RNA was not clearly observed in either the controls or
the butyrate alone-treated cells. Both LPS alone and butyrate with
LPS stimulations elevated the expression of IL-1β m-RNA levels
(Fig. 1). After 24 h, IL-1β m-RNA levels in both stimulations
remained elevated to a similar level (data not shown).
LPS alone increased IL-1β protein production in a time-
dependent manner compared to those in the controls or in butyrate
alone-treated cells. Butyrate with LPS significantly increased
IL-1β protein production compared to those in LPS alone-treated
cells (Fig. 2).
Butyrate with LPS enhances caspase 1 expression. Next,
we determined the caspase-1 protein expression. There was no
difference of caspase-1 expression in the controls or the butyrate
alone-treated cells. LPS alone significantly increased caspase-1
expression: more than 3-fold above the controls. Butyrate with
LPS also increased caspase-1 expression to a similar level, which
seems to match an earlier trend compared to LPS alone (Fig. 3 (a)
and (b)). These results suggested that IL-1β production in THP-1
cells by LPS alone or butyrate with LPS was mediated by caspase-1
activation.
Effect of kinase inhibitors and antioxidants on caspase 1
activity and IL 1β expression. First, to determine whether
butyrate affects the early activation of the MAPKs pathways to
induce IL-1β release, we examined phosphorylation of p38
MAPK, JNK1/2, MEK1/2 and ERK1/2 proteins. As shown in
Fig. 4, butyrate with LPS stimulation accelerated the phosphoryla-
tion of these proteins, which also occurred to a lesser extent in LPS
alone.
Next, to elucidate the mechanisms by which butyrate enhances
IL-1β production in LPS-stimulated cells, we examined the effect
of various protein kinase inhibitors or anti-oxidants on IL-1β
protein production and caspase-1 activity. Butyrate treatment
increased caspase-1 activity 3.7-fold and IL-1β protein production
110-fold (mean, 352.5 pg/ml) compared to the control cells
(DMSO only). Ac-YVAD-CHO (caspase-1 inhibitor) decreased
caspase-1 activity by 78% and IL-1β protein production by 88%.
Similarly: PD98059 (ERK1/2 inhibitor) by 46 and 49%; SB203580
(p38 MAPK inhibitor) by 54 and 63%; SP600125 (JNK1/2
inhibitor) by 43 and 57%; NAC (anti-oxidant) by 46 and 42%; DPI
[Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase
inhibitor] by 38 and 44%; and GF109203X (protein kinase C
inhibitor) by 11 and 6% (Fig. 5 (a) and (b)).
Moreover, we found that pre-treatment with PTX reduced IL-1β
protein production by approximately 50% compared to cells
Fig. 4. Effects of lipopolysaccharide (LPS) and butyrate on mitogen activated protein kinase (MAPK) cascade pathways. Cells were seeded onto a
60 mm tissue culture dish at a density of 5 × 106 cells/dish and then cultured at 37°C for 48 h under a humidified atmosphere of 5% CO2. After
differentiation, cells were treated with phosphate buffered saline (PBS); control, 1 mmol/l butyrate alone, 0.1 μg/ml LPS alone, or 1 mmol/l butyrate
with 0.1 μg/ml LPS for 5, 10, 20, 30, 60, 120, and 180 min. The phosphorylation of p38 MAPK, c Jun NH2 terminal kinase1/2 (JNK1/2), mitogen 
activated protein kinase kinase1/2 (MEK1/2), and extracellular signal regulated kinase1/2 (ERK1/2) was analyzed by Western blotting as described in
Materials and Methods. Actin was used as the internal control. The pictures are representative results from three independent experiments. J. Clin. Biochem. Nutr. | January 2012 | vol. 50 | no. 1 | 63
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without PTX (Fig. 6). These results suggest that butyrate with LPS
accelerates IL-1β protein production via oxidative mechanisms
and the protein phosphorylation pathways involving MAP kinase
and Gi protein-mediated signaling.
Butyrate with LPS enhances nitrite/nitrate production via
ROS generation. Next, to determine influence of butyrate on
ROS production, we used flow cytometry to measure intracellular
ROS in THP-1 cells treated with LPS alone and butyrate with LPS.
As shown in Fig. 7(a), the control cells exhibited constitutive basal
levels of ROS, and the LPS increased these. Butyrate with LPS
increased ROS levels to an even greater extent. The addition of
NAC, however, reduced ROS levels to a level similar to that seen
in LPS alone-treated cells (Fig. 7(b)). We also examined the
effects of nitrite/nitrate production. Butyrate with LPS signifi-
cantly increased nitrite/nitrate production compared to LPS alone
(Fig. 8). The addition of NAC resulted in a significant reduction in
the elevated amount of nitrite/nitrate by butyrate with LPS.
Fig. 5. Effects of kinase inhibitors and an antioxidant on caspase 1
activity and interleukin 1β (IL 1β) in THP 1 cells treated with butyrate
and lipopolysaccharide (LPS). After differentiation, cells were seeded
onto a 60 mm dish (caspase 1) or a 24 well plate (IL 1β) at a density of
1 × 106 cells/well and 5 × 106 cells/dish, respectively, in RPMI 1640 medium.
After washing, the cells were treated with the vehicle (0.5% v/v
dimethylsulfoxide (DMSO)), 100 mmol/l Ac YVAD CHO (YVAD), 50 mmol/l
PD98059 (PD), 50 mmol/l SB203580 (SB), 10 mmol/l SP600125 (SP),
20 mmol/l N acetyl L cysteine (NAC), 10 mmol/l diphenyleneiodonium
(DPI), and 10 mmol/l GF109203X (GF). Additional inhibitors or anti 
oxidants cells were incubated at 37°C for 20 min, and then were treated
with 0.1 μg/mL LPS alone or 1 mmol/l butyrate with 0.1 μg/ml LPS for
24 h. (a) shows the caspase 1 activity by fluorometric assay. The values
in five independent experiments are expressed as fold increase (the
mean ± SD) relative to that of the controls. (b) shows IL 1β concentra 
tions measured by ELISA kit. The values in five independent experi 
ments are expressed as the mean ± SD. *p<0.05 vs LPS alone. #p<0.05,
##p<0.01,  ###p<0.001 vs butyrate with LPS, by Kruskall Wallis variance
analysis and Dunnet’s multiple comparison test.
Fig. 6. Effects of pertussis toxin (PTX) on interleukin 1β (IL 1β) produc 
tion in THP 1 cells. Cells were seeded onto a 24 well plate at a density of
1 × 106 cells/well, and then cultured at 37°C for 24 h under a humidified
atmosphere of 5% CO2. After differentiation, cells were treated with
the 100 ng/ml PTX, and incubating at 37°C for 1 h. They were then
treated with 0.1 μg/ml lipopolysaccharide (LPS) alone or 1 mmol/l
butyrate with 0.1 μg/ml LPS for 24 h. IL 1β protein concentrations in
the medium were examined by ELISA kit. The values in five indepen 
dent experiments are expressed as the mean ± SD. Statistical analysis
was performed using the Mann Whitney U test, **p<0.01, vs without
PTX treatment.
Fig. 7. Effects of butyrate and N acetyl L cysteine (NAC) on reactive
oxygen species (ROS) production in THP 1 cells. After differentiation,
cells were incubated with 0.1 μg/ml lipopolysaccharide (LPS) alone or
1 mmol/l butyrate with 0.1 µg/ml LPS, or 1 mmol/l butyrate with 0.1 µg/ml
LPS and 20 mmol/l NAC, for 1 h. Then, cells were stained with carboxy 
H2DCFDA for 30 min. The amount of ROS was determined by FACS
analysis. (a) shows the effect of LPS alone and LPS with butyrate. (b)
shows the effects of butyrate with LPS, and butyrate with LPS and NAC.
Each result is a representative one from three independent experiments.doi: 10.3164/jcbn.11 22
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Discussion
In this study, we demonstrated that LPS induced IL-1β produc-
tion in THP-1 cells and that butyrate enhanced this production.
Butyrate also enhanced caspase-1 activation, ROS production, the
phosphorylation pathways involving MAP kinase, and Gi protein-
mediated signaling. The PKC inhibitor used in this study did not
show any effects. These results seem to demonstrate that butyrate
enhances IL-1β production by activating caspase-1 via ROS and
the phosphorylation of MAPK pathways and the Gi protein-
mediated pathways.
G protein-coupled receptors (GPCRs) constitute one type of
receptor localized in the cell membrane, and are also known as
seven trans-membrane domain receptors. In recent years, it has
been reported that two GPCRs (GPR41 and GPR43) have an
affinity for SCFAs.(10–13)
Le Poul et al.(11) reported that GPR41 and 43 bound to a short-
chain fatty acid acts as a chemo-attractant signal for peripheral
blood mononuclear cells. They showed that stimulation of GPR41
and 43 increased the intracellular Ca2+ level by SCFA and that
PTX abolished the response of GPR41 but not of GPR43.
Although details regarding the GPCR signal cascade are still not
well understood, signal pathways involving non-receptor tyrosine
kinases,(12) such as phosphatidylinositol 3-kinase (PI3K)(13) and
protein kinase C (PKC),(14) may play a significant role in immune
reactions. It has been shown that GPR41 receptors are coupled
with Gi/o and that their activation induces the formation of inositol
1,4,5-trisphosphate, increases intracellular Ca2+ concentration and
ERK1/2 activation, and decreases intracellular cyclic adenosine
monophosphate (cAMP).(11) In this study, we were able to identify
the association of Gi protein, although we did not examine the
direct association of GPR41 in IL-1β production by butyrate. In
the future, we aim to clarify the detailed mechanisms involved in
GPR41 in IL-1β production by butyrate.
NADPH oxidase is the primary enzyme for ROS generation in
phagocytic cells.(15) Excessive ROS stimulate MAPK pathway
activation(16) and activate MAPKs promote casapse-1 and IL-1β
expression.(17) Our results seem to be consistent with these reports.
Therefore, we postulated that butyrate may lead to accelerated
NADPH oxidase activity resulting in increased activation of p38
MAPK, JNK 1/2, MEK1/2, and ERK1/2 pathways, the activation
of caspase-1, and finally more mature efficient IL-1β production.
However, there is also a possibility that ROS may directly activate
caspase-1 through a redox-sensitive cysteine residue.(18) Because
p38 MAPK, JNK, MEK inhibitors are not fully effective and
because an increase in caspase-1 expression was observed earlier
in the butyrate-treated cells than in cells given LPS alone, it
appears that partial intervention of the direct path needs to be
considered.
SCFAs such as acetate, propionate, and butyrate are produced
by anaerobic bacterial fermentation of undigested carbohydrates
in the colon,(19) and they are rapidly absorbed to provide energy for
the colorectal epithelium by means of increased blood flow in
rectal mucosa.(20) SCFAs also induce apoptosis in a number of
colorectal tumor cell lines.(21) On the other hand, butyrate has anti-
inflammatory effects in the colon,(22) and it also has a prominent
immunity regulation effect by modulating IL-8(23) and macrophage
inflammatory protein 2 (MIP-2) activities(24) and suppressing the
NF-κB activity,(25,26) leading to the regulation of inflammatory
cytokines such as TNF-α, IL-6, IL-8, and others.(27,28)
However, the results of a controlled clinical trial that used
enemas containing sodium butyrate showed that butyrate was not
effective in the treatment of UC,(29,30) suggesting that butyrate’s
immune control mechanisms use pathways that may lead to both
suppression and aggravation. As shown in this study, butyrate may
have a significant influence on the production of IL-1β. Our data
can be applied to strategies for preventing anaerobic bacteria from
producing butyrate, which may be an effective treatment of IBD.
Pharmacological inhibition of p38 MAPK, JNK 1/2, MEK1/2,
and ERK1/2 seems to be beneficial effects for the treatment of
inflammatory responses based on experiments with animal
models,(31,32) and IL-1β has been reduced by the inhibition of p38
MAPK phosphorylation in the rat dentate gyrus in vitro.(33)
This study has some limitations. For example, we found that
Fig. 8. Effects of butyrate and N acetyl L cysteine (NAC) on nitric oxide (NO) production in THP 1 cells. After differentiation, cells were treated
with 0.5% v/v dimethylsulfoxide; DMSO (the controls, closed circle), 1 mmol/l butyrate (open square), 0.5 μg/ml lipopolysaccharide; LPS alone (open
circle), 1 mmol/l butyrate with 0.5 µg/ml LPS (open triangle), 0.5 µg/ml LPS with 20 mmol/l NAC (closed square), or 1 mmol/l butyrate with 0.5 µg/ml LPS
and 20 mmol/l NAC (closed triangle) for 6, 12, and 24 h. NO production from THP 1 cells was determined by measuring the amount of nitrite/nitrate
as described in Materials and Methods. The values from five independent experiments are expressed as the mean ± SD. *p<0.05 vs LPS alone,
##p<0.01 vs LPS with butyrate, by Kruskall Wallis variance analysis and Dunnet’s multiple comparison test. J. Clin. Biochem. Nutr. | January 2012 | vol. 50 | no. 1 | 65
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butyrate-mediated induction of activated p38 MAPK occurred
within 10 min, nitrite detection outside the cell occurred after 6 h,
and intracellular detection of ROS occurred after 60 min. These
time lags may be due to the reaction time for NO detection in the
medium and the reagent sensitivity of the DCFH-DA fluorescent
probe for intracellular ROS detection. Moreover, the LPS concen-
tration (0.1 μg/ml) used to alter NO production in the culture
medium was below the lower detection limit. A higher concentra-
tion (0.5 μg/ml) should be used to examine these problems.
In conclusion, butyrate enhances IL-1β production by activating
caspase-1 via ROS and the phosphorylation of MAPK pathways
and the Gi protein mediated pathway in LPS stimulated THP-1
cells.
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IBD Inflammatory bowel diseases
IL-1β Interleukin-1β
JNK1/2 c-Jun NH2-terminal kinase1/2
LPS Lipopolysaccharide
MAPK Mitogen-activated protein kinase
MEK1/2 Mitogen-activated protein kinase kinase1/2
NAC N-acetyl L-cysteine
NADPH Nicotinamide adenine dinucleotide phosphate
NO Nitric oxide
NO2– Nitrite
NO3– Nitrate
PBS Phosphate buffered saline
PD PD98059
PMA Phorbol 12-myristate 13-acetate
PTX Pertussis toxin
ROS Reactive oxygen species
RT-PCR Reverse transcription-polymerase chain reaction
SB SB203580
SCFAs Short chain fatty acids
SP SP600125
UC Ulcerative colitis
YVAD Ac-YVAD-CHO
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